Short description
NephroGenex is a drug-development company focusing on kidney disease and progression of diabetic kidney disease.
Description
NephroGenex is a drug-development company focusing on kidney disease. The Company is developing Pyridorinâ„¢ (pyridoxamine dihydrochloride) as a treatment to slow the progression of diabetic kidney disease.
Last funding
Nopepepe
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Princeton, New Jersey, United States, North America
Founded on
January 1, 2004
Exited on
February 11, 2014
Went public on
February 11, 2014
Delisted on
May 11, 2016
Stock symbol
NRX
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccessforu, Uh Ohhhh, Blurry Noaccess, Nopepepe
Sign in for full access
Founders
Wesley Fox